ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
Chronic Myelomonocytic Leukemia

Acute Myeloid Leukemia (AML) trials near Louisville, KY, USA:

A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary anti-leukemic activity of WU-NK-101 in R/R AML....

Active, not recruiting
Acute Myeloid Leukemia
Biological: WU-NK-101

Phase 1

Wugen, Inc.

Louisville, Kentucky, United States and 8 other locations

Anti-tumor Activity of LYT- 200 in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML), or with Relaps...

Enrolling
AML, Adult Recurrent
MDS
Drug: Azacitidine
Drug: Decitabine

Phase 1

PureTech Health

Louisville, Kentucky, United States and 10 other locations

to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Pevonedistat
Drug: Venetoclax

Phase 2

Takeda
Takeda

Louisville, Kentucky, United States and 56 other locations

\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Fludarabine

Phase 3

LLS PedAL Initiative, LLC

Louisville, Kentucky, United States and 82 other locations

Locations recently updated

Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...

Enrolling
Myeloid Sarcoma
Nucleophosmin 1-mutated Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Cytarabine

Phase 1

Kura Oncology

Louisville, Kentucky, United States and 43 other locations

This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Louisville, Kentucky, United States and 160 other locations

to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukemia (AML) with a mutation ...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Louisville, Kentucky, United States and 140 other locations

Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Placebo
Drug: Azacitidine

Phase 3

AbbVie
AbbVie

Louisville, Kentucky, United States and 171 other locations

The purpose of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute ...

Active, not recruiting
Leukemia, Myeloid, Acute
Drug: Azacitidine
Drug: Venetoclax

Phase 1

OncoVerity

Louisville, Kentucky, United States and 22 other locations

with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...

Enrolling
Acute Myeloid Leukemias
Drug: SNDX-5613
Drug: Chemotherapy Regimen

Phase 1

Syndax Pharmaceuticals
Syndax Pharmaceuticals

Louisville, Kentucky, United States and 36 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems